RSS-Feed abonnieren
DOI: 10.1055/a-1678-7092
Association Between Prediabetes and Retinopathy: A Meta-Analysis
Gefördert durch: National Natural Science Foundation of China 81671641Gefördert durch: Suzhou Science and Technology Fund of China No. SYS2020137

Abstract
Diabetes confers an increased risk of microvascular complications, including retinopathy. However, whether prediabetes is also related to retinopathy has not been comprehensively examined. We performed a meta-analysis to evaluate the relationship between prediabetes and retinopathy. This meta-analysis included relevant observational studies from Medline, Embase, and Web of Science databases. A random-effect model after incorporation of the intra-study heterogeneity was selected to pool the results. Subgroup analyses were applied to evaluate the influences of study characteristics on relationship. Nine cross-sectional studies including 14 751 community dwelling adult participants were included; 3847 (26.1%) of them were prediabetic. Results showed that prediabetes was associated with a higher prevalence of retinopathy compared to normoglycemia [odds ratio (OR): 1.55, 95% confidence interval (CI): 1.10–2.20, p=0.01, I2=34%]. Sensitivity analysis by excluding one study at a time showed consistent result (OR: 1.35 to 1.73, p all<0.05). Subgroup analysis showed study characteristics such as definition of prediabetes, country of study, sample size, mean age of participants, or univariate or multivariate analyses may not significantly affect the association (p for subgroup difference all>0.05). Current evidence suggests that patients with prediabetes may be associated with higher prevalence of retinopathy as compared to those with normoglycemia. Although prospective cohort studies are needed to validate these findings, results of our meta-analysis highlighted the importance of early prevention of retinopathy in patients with prediabetes.
Publikationsverlauf
Eingereicht: 29. September 2021
Angenommen nach Revision: 19. Oktober 2021
Artikel online veröffentlicht:
10. Dezember 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart,
Germany
-
References
- 1 Crabtree GS, Chang JS. Management of complications and vision loss from proliferative diabetic retinopathy. Curr Diab Rep 2021; 21: 33
- 2 Nian S, Lo ACY, Mi Y. et al Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets. Eye Vis (Lond) 2021; 8: 15
- 3 Kramer CK, Rodrigues TC, Canani LH. et al Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: Meta-analysis of observational studies. Diabetes Care 2011; 34: 1238-1244
- 4 Xu XH, Sun B, Zhong S. et al Diabetic retinopathy predicts cardiovascular mortality in diabetes: A meta-analysis. BMC Cardiovasc Disord 2020; 20: 478
- 5 Cho NH, Shaw JE, Karuranga S. et al IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271-281
- 6 Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018; 14: 88-98
- 7 Tabak AG, Herder C, Rathmann W. et al Prediabetes: A high-risk state for diabetes development. Lancet 2012; 379: 2279-2290
- 8 Guasch-Ferre M, Hruby A, Toledo E. et al Metabolomics in prediabetes and diabetes: A systematic review and meta-analysis. Diabetes Care 2016; 39: 833-846
- 9 Rajpal A, Ismail-Beigi F. Intermittent fasting and 'metabolic switch': effects on metabolic syndrome, prediabetes and type 2 diabetes. Diabetes Obes Metab 2020; 22: 1496-1510
- 10 Sallar A, Dagogo-Jack S. Regression from prediabetes to normal glucose regulation: State of the science. Exp Biol Med (Maywood) 2020; 245: 889-896
- 11 Hostalek U. Global epidemiology of prediabetes - present and future perspectives. Clin Diabetes Endocrinol 2019; 5: 5
- 12 Chatterton H, Younger T, Fischer A. et al Risk identification and interventions to prevent type 2 diabetes in adults at high risk: Summary of NICE guidance. BMJ 2012; 345: e4624
- 13 [Anonymous] Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care 2019; 42: S13-S28
- 14 Cai X, Zhang Y, Li M. et al Association between prediabetes and risk of all cause mortality and cardiovascular disease: Updated meta-analysis. BMJ 2020; 370: m2297
- 15 Huang Y, Cai X, Chen P. Associations of prediabetes with all-cause and cardiovascular mortality: A meta-analysis. Ann Med 2014; 46: 684-692
- 16 Rajala U, Laakso M, Qiao Q. et al Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance. Diabetes Care 1998; 21: 1664-1669
- 17 Tapp RJ, Shaw JE, Harper CA. et al The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003; 26: 1731-1737
- 18 Kawasaki R, Wang JJ, Rochtchina E. et al Cardiovascular risk factors and retinal microvascular signs in an adult Japanese population: the Funagata study. Ophthalmology 2006; 113: 1378-1384
- 19 Munch IC, Kessel L, Borch-Johnsen K. et al Microvascular retinopathy in subjects without diabetes: the Inter99 eye study. Acta Ophthalmol 2012; 90: 613-619
- 20 Pang C, Jia L, Jiang S. et al Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diabetes Metab Res Rev 2012; 28: 276-283
- 21 Sundling V, Platou CG, Jansson RW. et al Retinopathy and visual impairment in diabetes, impaired glucose tolerance and normal glucose tolerance: the Nord-Trondelag health study (the HUNT study). Acta Ophthalmol 2012; 90: 237-243
- 22 Hu Y, Teng W, Liu L. et al Prevalence and risk factors of diabetes and diabetic retinopathy in Liaoning province, China: A population-based cross-sectional study. PLoS One 2015; 10: e0121477
- 23 Sokolowska-Oracz A, Litwinczuk-Hajduk J, Piatkiewicz P. Prevalence of ocular abnormalities in prediabetic patients. Klin Oczna 2016; 118: 23-28
- 24 Hanssen NMJ, Scheijen J, Houben A. et al Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study. Diabetes Metab 2021; 47: 101148
- 25 Stroup DF, Berlin JA, Morton SC. et al Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012
- 26 Higgins J, Green S. Cochrane Handbook for Systematic Reviews of interventions version 5.1.0. The Cochrane Collaboration 2011 www.cochranehandbook.org
- 27 Wilkinson CP, Ferris FL, Klein RE. et al Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-1682
- 28 Wells GA, Shea B, O'Connell D. et al The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010 http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
- 29 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558
- 30 Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 2008; 37: 1148-1157
- 31 Egger M, Davey Smith G, Schneider M. et al Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
- 32 Rett K, Gottwald-Hostalek U. Understanding prediabetes: definition, prevalence, burden and treatment options for an emerging disease. Curr Med Res Opin 2019; 35: 1529-1534
- 33 Shilpasree AS, Patil VS, Revanasiddappa M. et al Renal dysfunction in prediabetes: confirmed by glomerular hyperfiltration and albuminuria. J Lab Physicians 2021; 13: 257-262
- 34 Kang Q, Yang C. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol 2020; 37: 101799
- 35 Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci 2018; 19: 1816
- 36 Gui F, You Z, Fu S. et al Endothelial dysfunction in diabetic retinopathy. Front Endocrinol (Lausanne) 2020; 11: 591
- 37 Perreault L, Pan Q, Schroeder EB. et al Regression from prediabetes to normal glucose regulation and prevalence of microvascular disease in the diabetes prevention program outcomes study (DPPOS). Diabetes Care 2019; 42: 1809-1815